2020 American Transplant Congress
Cardiovascular Risk Factors in Patients after Liver Transplantion
*Purpose: The aim of this study was to estimate the prevalence of selected cardiovascular risk factors in patients after liver transplantation (LTx).*Methods: Medical records from…2020 American Transplant Congress
Progression of Insulin Resistance after Liver Transplantation – Prospective Study
*Purpose: Insulin resistance (IR) plays an important role in pathogenesis of nonalcoholic fatty liver disease (NAFLD) and other diseases. The data about prevalence and evolution…2020 American Transplant Congress
New-Onset Diabetes after Adult Liver Transplantation in the Korean Organ Transplantation Registry Study
*Purpose: New-onset diabetes after transplantation (NODAT) is a serious complication following liver transplantation (LT). The present study aimed to investigate the incidence of and risk…2020 American Transplant Congress
Significant Costs Associated with Poorly Controlled Post-Transplant Blood Glucose
*Purpose: Dysglycemia is highly prevalent post-transplant. Poor glycemic control is associated with infectious and cardiovascular complications, as well as decreased patient and allograft survival. We…2019 American Transplant Congress
Use of GLP-1 Receptor Agonists in Kidney Transplant Recipients with Type 2 Diabetes
*Purpose: GLP-1 receptor agonists have been shown to improve glucose control and diabetes-related comorbidities, including obesity, cardiovascular disease and chronic kidney disease, in non-transplant patients.…2019 American Transplant Congress
Pharmacist-Led Management of Post-Transplant Hyperglycemia Reduces Hospitalizations
*Purpose: Renal transplant recipients (RTRs) are at risk of developing post-transplant hyperglycemia (PTHG), defined as blood glucose > 180 mg/dL within the first 45 days…2019 American Transplant Congress
Insulin Resistance as a Surrogate Marker for Post-Transplantation Diabetes Mellitus
Department of Medicine, Division of Nephrology, Federal University of São Paulo, São Paulo, Brazil
*Purpose: Post-transplantation diabetes mellitus (PTDM) adversely impact patient and kidney allograft survival. Further knowledge of the risk factors involved in the onset and progression of…2019 American Transplant Congress
Prevalence of Diabetes after Transplant in a Single Center
*Purpose: The investigators aim to study the prevalence of post kidney transplant diabetes (NODAT) in a single Asian pediatric centre and to identify clinical factors…2019 American Transplant Congress
Prevention of Diabetes in the NOD Mice Reconstituted with Bone Marrow Cells from Allogeneic CD4 Knockout, CD8 Knockout or B-Cell Knockout B6 Mice
University of Louisville, Louisville, KY
*Purpose: Type 1 diabetes (T1D) is an autoimmune disorder characterized by destruction of the pancreatic beta cells by both humoral- and cell-mediated immune mechanisms. Transplantation…2019 American Transplant Congress
Prevention of Islet Allo- and Xenograft Rejection with Immunoglobulin M Immunotherapy
Surgery, University of Virginia, Charlottesville, VA
*Purpose: To investigate if IgM therapy mitigates islet allo- and xenotransplant rejection and promotes permanent islet survival.*Methods: 1) New onset diabetic NOD mice (n=14) were…
American Transplant Congress abstracts